Literature DB >> 7487624

Pathologic human vitreous promotes contraction by fibroblasts. Implications for proliferative vitreoretinopathy.

C Hardwick1, R Morris, D Witherspoon, M White, R Feist, R McFarland, C Guidry.   

Abstract

OBJECTIVE: To establish and quantify the presence of contraction-stimulating activity in pathologic vitreous and correlate this activity with clinical presentation and outcome, especially with proliferative vitreoretinopathy.
METHODS: Contraction-stimulating activity of vitreous collected during surgery was quantified with a tissue culture assay using fibroblasts as target cells. The activity of each sample was correlated with patient history, clinical presentation, risk factors, proliferative disease, and postoperative proliferation.
RESULTS: Pathologic vitreous contained measurable quantities of contraction-stimulating activity and stimulated contraction in vitro, with elevated activities in samples from patients with proliferative vitreoretinopathy, epimacular proliferation, retinal detachment, retinal defects, pigmented cells in the vitreous, hemorrhage, or uveitis. Patients with postoperative proliferation had significantly elevated mean activities.
CONCLUSIONS: Levels of contraction-stimulating activity in pathologic vitreous correlate with some risk factors for the development of proliferative vitreoretinopathy and may ultimately be useful in the assessment of disease severity and the prediction of postoperative proliferation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7487624     DOI: 10.1001/archopht.1995.01100120075013

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  6 in total

1.  [Vitreal-induced RPE cell traction. Investigation of pathological vitreous samples in an in vitro contraction model].

Authors:  J Beutel; M Lüke; K-U Bartz-Schmidt; S Grisanti
Journal:  Ophthalmologe       Date:  2009-10       Impact factor: 1.059

2.  Vitreous IGFBP-3 effects on Müller cell proliferation and tractional force generation.

Authors:  Jeffery L King; Clyde Guidry
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-05       Impact factor: 4.799

3.  Risk of Retinal Neovascularization in Cases of Uveitis.

Authors:  Apurva K Patel; Craig W Newcomb; Teresa L Liesegang; Siddharth S Pujari; Eric B Suhler; Jennifer E Thorne; C Stephen Foster; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; H Nida Sen; Pichaporn Artornsombudh; Srishti Kothari; John H Kempen
Journal:  Ophthalmology       Date:  2015-12-11       Impact factor: 12.079

4.  Cell-mediated contraction of vitreous explants from chicken embryo: possibility of screening for therapeutic agents against proliferative vitreoretinal diseases.

Authors:  Keitaro Oki; Yoshiki Miyata; Arata Shimada; Terumasa Nagase; Yoshiya Katsura; Hiroshi Kosano
Journal:  Mol Vis       Date:  2013-11-23       Impact factor: 2.367

Review 5.  Mechanisms of inflammation in proliferative vitreoretinopathy: from bench to bedside.

Authors:  Stavros N Moysidis; Aristomenis Thanos; Demetrios G Vavvas
Journal:  Mediators Inflamm       Date:  2012-09-25       Impact factor: 4.711

Review 6.  Inflammatory and Fibrogenic Factors in Proliferative Vitreoretinopathy Development.

Authors:  Rishika Chaudhary; Robert A H Scott; Graham Wallace; Martin Berry; Ann Logan; Richard J Blanch
Journal:  Transl Vis Sci Technol       Date:  2020-02-21       Impact factor: 3.283

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.